Thermo Fisher Scientific Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was Laboratory Products And Biopharma Services at $23.8 billion, 53% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Product Consumables at $18.7 billion, 42% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 26, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
47,351
|
44,556
|
42,879
|
42,857
|
44,915
|
39,211
|
32,218
|
25,542
|
24,358
|
20,918
|
18,274
|
| Operating segments | |||||||||||
| Laboratory Products And Biopharma Services |
25,802
+10.4%
share 54.5%
|
23,818
+3.5%
share 53.5%
|
23,002
+0.5%
share 53.6%
|
22,888
+2.6%
share 53.4%
|
22,304
share 49.7%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Life Sciences Solutions |
9,371
+10.4%
share 19.8%
|
8,781
+7.6%
share 19.7%
|
8,160
-4.5%
share 19.0%
|
8,545
-26.1%
share 19.9%
|
11,565
share 25.7%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Analytical Instruments |
7,574
+3.4%
share 16.0%
|
7,353
+1.2%
share 16.5%
|
7,267
+2.3%
share 16.9%
|
7,101
+10.2%
share 16.6%
|
6,441
share 14.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Specialty Diagnostics |
4,604
+1.4%
share 9.7%
|
4,604
+3.5%
share 10.3%
|
4,449
+2.9%
share 10.4%
|
4,324
-6.1%
share 10.1%
|
4,604
share 10.3%
|
—
|
—
|
—
|
—
|
—
|
—
|
| Sales mix | |||||||||||
| Product Consumables |
19,691
+8.5%
share 41.6%
|
18,664
+6.1%
share 41.9%
|
17,587
-0.1%
share 41.0%
|
17,597
-14.7%
share 41.1%
|
20,624
-8.8%
share 45.9%
|
22,608
+22.0%
share 57.7%
|
18,527
+41.3%
share 57.5%
|
13,109
+4.2%
share 51.3%
|
12,576
share 51.6%
|
—
|
—
|
| Services |
20,252
+11.0%
share 42.8%
|
18,592
+4.2%
share 41.7%
|
17,845
+1.3%
share 41.6%
|
17,614
+7.6%
share 41.1%
|
16,367
+84.9%
share 36.4%
|
8,850
+28.0%
share 22.6%
|
6,912
+14.3%
share 21.5%
|
6,046
+10.1%
share 23.7%
|
5,490
+54.9%
share 22.5%
|
3,544
share 16.9%
|
—
|
| Product Instruments |
7,409
+1.1%
share 15.6%
|
7,301
-1.9%
share 16.4%
|
7,446
-2.6%
share 17.4%
|
7,646
-3.5%
share 17.8%
|
7,924
+2.2%
share 17.6%
|
7,753
+14.4%
share 19.8%
|
6,779
+6.1%
share 21.0%
|
6,387
+1.5%
share 25.0%
|
6,292
share 25.8%
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Measuring & Controlling Devices, NEC (SIC 3829)
- Listed as
- TMO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 97745
- Former names
- THERMO ELECTRON CORP (until Nov 3, 2006)
Other Measuring & Controlling Devices, NEC companies
- Rockwell Automation, Inc ROK
- Trimble Inc. TRMB
- Onto Innovation Inc. ONTO
- Mirion Technologies, Inc. MIR
- Quantum-Si Inc QSI
- Owlet, Inc. OWLT
- Geospace Technologies Corp GEOS
- Birchtech Corp. BCHT
Source: SEC EDGAR filings. This is company-reported data, not investment advice.